Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06364644 · ClinicalTrials.gov registry record · NA
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
A NA study of Obesity and Heart Failure, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 2
- Study locations
NCT06364644: Recruiting NA study of Obesity and Heart Failure, sponsored by Johns Hopkins University.
NCT06364644 is a NA study of Obesity and Heart Failure that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 210 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06364644, a NA study of Obesity and Heart Failure, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving outcomes for individuals with low socioeconomic status, type 2 diabetes, obesity, and early cardiac dysfunction than receiving education and access to a community exercise facility.
Primary Outcome
Total distance walked in the 6 minutes walk test in meters
Conditions Studied
Interventions
- BEHAVIORAL Community Champions
- BEHAVIORAL Homegrown Heroes
Study Locations (2)
Maryland
- Johns Hopkins Center for Health Equity - Baltimore
- Johns Hopkins University Comstock Center - Hagerstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT06364644 shows while recruiting
NCT06364644 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Community Champions is the first listed.
NCT06364644 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06364644 about?
NCT06364644 is a clinical study titled "Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure". This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving outcomes for individuals with low socioeconomic status, type 2 diabetes, obesity, and early cardiac dy...
What is the current status of trial NCT06364644?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2025-06-20. Estimated completion is 2027-03.
What conditions does trial NCT06364644 study?
This clinical trial studies the following conditions: Obesity, Heart Failure, Type 2 Diabetes.
What interventions are being tested in trial NCT06364644?
The interventions under investigation include: Community Champions (BEHAVIORAL), Homegrown Heroes (BEHAVIORAL).
Who is sponsoring clinical trial NCT06364644?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06364644 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06364644's enrollment target sits among peer trials
210 303rd of 1053 higher than 748 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI